Glofitamab

ATC L01FX28 · 9 markets · 18 records

Glofitamab 9 markets · 18 records Forms

AU 5 records · 5 strengths

  • 10 mg/10 mLinjectionColumvi also in GB
  • 10 mginjectionCOLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial also in ES unknown
  • 2.5 mg/2.5 mLinjectionColumvi also in GB
  • 2.5 mginjectionCOLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial also in ES unknown

Records without a stated strength · 1 Columvi

US 2 records · 2 strengths

GB 2 records · 2 strengths

CA 2 records · 1 strengths

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 COLUMVI CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/10ML

    SG 1 records · 1 strengths

    • 1 mg/mLinjectionCOLUMVI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML

    TW 1 records · 1 strengths

      Records without a stated strength · 1 Columvi solution for infusion、利癌妥 注射劑

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Columvi

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.